INFECTIOUS DISEASE. Vaginal microbiome affects HIV risk

Science. 2016 Jul 22;353(6297):331. doi: 10.1126/science.353.6297.331.
No abstract available

Publication types

  • News

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / epidemiology*
  • Acquired Immunodeficiency Syndrome / prevention & control
  • Anti-HIV Agents / administration & dosage
  • Clinical Trials as Topic
  • Female
  • Humans
  • Inflammation / microbiology
  • Lactobacillus / isolation & purification
  • Microbiota / drug effects
  • Microbiota / physiology*
  • Pre-Exposure Prophylaxis
  • Prevotella / isolation & purification
  • Risk
  • South Africa / epidemiology
  • Tenofovir / administration & dosage
  • Vagina / microbiology*
  • Vaginal Creams, Foams, and Jellies / administration & dosage

Substances

  • Anti-HIV Agents
  • Vaginal Creams, Foams, and Jellies
  • Tenofovir